Source link : https://www.newshealth.biz/health-news/fda-oks-updated-novavax-covid-shot/
The FDA granted emergency use authorization (EUA) for an updated Novavax COVID-19 vaccine to protect against hospitalization and death from circulating variants. The protein-based shot represents a non-mRNA option for the 2024-2025 season, and follows the agency’s recent approvals and authorizations of the updated Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty) vaccines. “The COVID-19 vaccines have had […]
Author : News Health
Publish date : 2024-09-03 16:12:14
Copyright for syndicated content belongs to the linked Source.